Based on the combinatorial analysis of bioinformatics and functional screening, clathrin heavy chain (CLTC) was selected and confirmed as a new biomarker and potential therapeutic target for patients with osteosarcoma. The gene discussed is CLTC; the disease is osteosarcoma.